HK-listed WuXi XDC hits 10-month peak on solid first-half results

WuXi Biologics (Cayman)

25/08/2026 03:44

** Shares of Chinese drugmaker WuXi XDC 2268.HK jump 12% to HK$78.2, their highest point since October 9, 2025 
** Stock posts its biggest intraday pct rise since March 2025
** Stock is top pct gainer in Hang Seng Biotech Index .HSBIO, which climbs 1.4%
** The WuXi Biologics-backed 2269.HK company says its first-half revenue up 37% y/y at 3.7 billion yuan ($550.19 million) with adjusted net profit attributable up 37.4% y/y at 1.03 billion yuan and gross profit margin up 0.9 percentage points to 37% 
** Shares of WuXi Biologics climb 4.9% to HK$51, their biggest intraday pct gain since August 18 
** YTD, WuXi XDC stock up 26.7%, WuXi Biologics up 59.2%, Hang Seng Biotech Index .HSBIO up 11.3%
     
($1 = 6.7249 Chinese yuan)

 (Reporting by Donny Kwok)
 ((donny.kwok@thomsonreuters.com))